John Tsai, Head of Global Drug Development and Chief Medical Officer, describes how he balances innovation and patient needs.

The race is on to find a new treatment before resistance to today’s drugs becomes widespread.

Jay Bradner discusses his vision for an open framework of scientific discovery at Novartis.

We’re working to bring the hope of advanced medicine to more patients.

Our Global Head of Precision Medicine in Oncology discusses her day-to-day work at Novartis.

New Global Head of Ophthalmology Research sees the eye as a frontier of biomedical research.

Jennifer Leeds offers a behind-the-scenes look at the consortia forming to address COVID-19.

Functional genomics study reveals a potential approach for tackling glioblastoma, pancreatic cancer and other tumors.